Literature DB >> 27109146

Two cases of RIT1 associated Noonan syndrome: Further delineation of the clinical phenotype and review of the literature.

Doris Milosavljević1,2, Eline Overwater1,3, Saskia Tamminga1, Karin de Boer4, Mariet W Elting1, Marion E van Hoorn5, Tuula Rinne6, Arjan C Houweling1.   

Abstract

Mutations in RIT1, involved in the RAS-MAPK pathway, have recently been identified as a cause for Noonan syndrome. We present two patients with Noonan syndrome caused by a RIT1 mutation with novel phenotypic manifestations, severe bilateral lower limb lymphedema starting during puberty, and fetal hydrops resulting in intrauterine fetal death, respectively. Including our patients, a total of 52 patients have been reported with Noonan syndrome caused by a RIT1 mutation. Our report contributes to the delineation of the phenotype associated with RIT1 mutations and underlines that lymphatic involvement is part of this spectrum. In addition, we provide an overview of the currently described Noonan syndrome patients with RIT1 mutations in literature.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Noonan syndrome; RASopathy; RIT1; hydrops fetalis; lymphedema

Mesh:

Substances:

Year:  2016        PMID: 27109146     DOI: 10.1002/ajmg.a.37657

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.

Authors:  Dong Li; Michael E March; Alvaro Gutierrez-Uzquiza; Charlly Kao; Christoph Seiler; Erin Pinto; Leticia S Matsuoka; Mark R Battig; Elizabeth J Bhoj; Tara L Wenger; Lifeng Tian; Nora Robinson; Tiancheng Wang; Yichuan Liu; Brant M Weinstein; Matthew Swift; Hyun Min Jung; Courtney N Kaminski; Rosetta Chiavacci; Jonathan A Perkins; Michael A Levine; Patrick M A Sleiman; Patricia J Hicks; Janet T Strausbaugh; Jean B Belasco; Yoav Dori; Hakon Hakonarson
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

Review 2.  Lymphatic Abnormalities in Noonan Syndrome Spectrum Disorders: A Systematic Review.

Authors:  Julia Sleutjes; Lotte Kleimeier; Erika Leenders; Willemijn Klein; Jos Draaisma
Journal:  Mol Syndromol       Date:  2021-09-10

3.  The molecular functions of RIT1 and its contribution to human disease.

Authors:  Richard Van; Antonio Cuevas-Navarro; Pau Castel; Frank McCormick
Journal:  Biochem J       Date:  2020-08-14       Impact factor: 3.857

4.  RIT1 controls actin dynamics via complex formation with RAC1/CDC42 and PAK1.

Authors:  Uta Meyer Zum Büschenfelde; Laura Isabel Brandenstein; Leonie von Elsner; Kristina Flato; Tess Holling; Martin Zenker; Georg Rosenberger; Kerstin Kutsche
Journal:  PLoS Genet       Date:  2018-05-07       Impact factor: 5.917

5.  Cognitive Phenotype and Psychopathology in Noonan Syndrome Spectrum Disorders through Various Ras/MAPK Pathway Associated Gene Variants.

Authors:  Ellen Wingbermühle; Renée L Roelofs; Wouter Oomens; Jennifer Kramer; Jos M T Draaisma; Erika Leenders; Tjitske Kleefstra; Roy P C Kessels; Jos I M Egger
Journal:  J Clin Med       Date:  2022-08-13       Impact factor: 4.964

6.  Prenatal cases with rare RIT1 variants causing severe fetal hydrops and death.

Authors:  Ieva Miceikaite; Geske Sidsel Bak; Martin Jakob Larsen; Britta Schlott Kristiansen; Pernille Mathiesen Torring
Journal:  Clin Case Rep       Date:  2021-07-21

Review 7.  Complicated ventricular arrhythmia and hematologic myeloproliferative disorder in RIT1-associated Noonan syndrome: Expanding the phenotype and review of the literature.

Authors:  Safwat A Aly; Kenneth M Boyer; Brie-Ann A Muller; Davide Marini; Carolyn H Jones; Hoang H Nguyen
Journal:  Mol Genet Genomic Med       Date:  2020-05-12       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.